Gastrooesophageal Cancer Active Not Recruiting Phase 1 / 2 Trials for Durvalumab (DB11714)

Also known as: GastroEsophageal Cancer

IndicationStatusPhase
DBCOND0041898 (Gastrooesophageal Cancer)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02318277A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)Treatment